Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Signs of Deregulated Gene Expression Are Present in Both CD14+ and CD14- PBMC From Non-Obese Men With Family History of T2DM

M. Koc, M. Šiklová, V. Šrámková, M. Štěpán, E. Krauzová, V. Štich, L. Rossmeislová

. 2020 ; 11 (-) : 582732. [pub] 20210215

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21019240

Aim: Development of type 2 diabetes (T2DM) is associated with disturbances in immune and metabolic status that may be reflected by an altered gene expression profile of peripheral blood mononuclear cells (PBMC). To reveal a potential family predisposition to these alterations, we investigated the regulation of gene expression profiles in circulating CD14+ and CD14- PBMC in fasting conditions and in response to oral glucose tolerance test (OGTT) in glucose tolerant first-degree relatives (FDR) of T2DM patients and in control subjects. Materials and Methods: This work is based on the clinical study LIMEX (NCT03155412). Non-obese 12 non-diabetic (FDR), and 12 control men without family history of diabetes matched for age and BMI underwent OGTT. Blood samples taken before and at the end of OGTT were used for isolation of circulating CD14+ and CD14- PBMC. In these cells, mRNA levels of 94 genes related to lipid and carbohydrate metabolism, immunity, and inflammation were assessed by qPCR. Results: Irrespectively of the group, the majority of analyzed genes had different mRNA expression in CD14+ PBMC compared to CD14- PBMC in the basal (fasting) condition. Seven genes (IRS1, TLR2, TNFα in CD14+ PBMC; ABCA1, ACOX1, ATGL, IL6 in CD14- PBMC) had different expression in control vs. FDR groups. OGTT regulated mRNA levels of nine genes selectively in CD14+ PBMC and of two genes (ABCA1, PFKL) selectively in CD14-PBMC. Differences in OGTT-induced response between FDR and controls were observed for EGR2, CCL2 in CD14+ PBMC and for ABCA1, ACOX1, DGAT2, MLCYD, and PTGS2 in CD14- PBMC. Conclusion: This study revealed a different impact of glucose challenge on gene expression in CD14+ when compared with CD14- PBMC fractions and suggested possible impact of family predisposition to T2DM on basal and OGTT-induced gene expression in these PBMC fractions. Future studies on these putative alterations of inflammation and lipid metabolism in fractionated PBMC in larger groups of subjects are warranted.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019240
003      
CZ-PrNML
005      
20210830100822.0
007      
ta
008      
210728s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fendo.2020.582732 $2 doi
035    __
$a (PubMed)33658980
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Koc, Michal $u Department for Pathophysiology, Centre for Research on Nutrition, Metabolism and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czechia
245    10
$a Signs of Deregulated Gene Expression Are Present in Both CD14+ and CD14- PBMC From Non-Obese Men With Family History of T2DM / $c M. Koc, M. Šiklová, V. Šrámková, M. Štěpán, E. Krauzová, V. Štich, L. Rossmeislová
520    9_
$a Aim: Development of type 2 diabetes (T2DM) is associated with disturbances in immune and metabolic status that may be reflected by an altered gene expression profile of peripheral blood mononuclear cells (PBMC). To reveal a potential family predisposition to these alterations, we investigated the regulation of gene expression profiles in circulating CD14+ and CD14- PBMC in fasting conditions and in response to oral glucose tolerance test (OGTT) in glucose tolerant first-degree relatives (FDR) of T2DM patients and in control subjects. Materials and Methods: This work is based on the clinical study LIMEX (NCT03155412). Non-obese 12 non-diabetic (FDR), and 12 control men without family history of diabetes matched for age and BMI underwent OGTT. Blood samples taken before and at the end of OGTT were used for isolation of circulating CD14+ and CD14- PBMC. In these cells, mRNA levels of 94 genes related to lipid and carbohydrate metabolism, immunity, and inflammation were assessed by qPCR. Results: Irrespectively of the group, the majority of analyzed genes had different mRNA expression in CD14+ PBMC compared to CD14- PBMC in the basal (fasting) condition. Seven genes (IRS1, TLR2, TNFα in CD14+ PBMC; ABCA1, ACOX1, ATGL, IL6 in CD14- PBMC) had different expression in control vs. FDR groups. OGTT regulated mRNA levels of nine genes selectively in CD14+ PBMC and of two genes (ABCA1, PFKL) selectively in CD14-PBMC. Differences in OGTT-induced response between FDR and controls were observed for EGR2, CCL2 in CD14+ PBMC and for ABCA1, ACOX1, DGAT2, MLCYD, and PTGS2 in CD14- PBMC. Conclusion: This study revealed a different impact of glucose challenge on gene expression in CD14+ when compared with CD14- PBMC fractions and suggested possible impact of family predisposition to T2DM on basal and OGTT-induced gene expression in these PBMC fractions. Future studies on these putative alterations of inflammation and lipid metabolism in fractionated PBMC in larger groups of subjects are warranted.
650    _2
$a dospělí $7 D000328
650    _2
$a biologické markery $x metabolismus $7 D015415
650    _2
$a krevní glukóza $x analýza $7 D001786
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a diabetes mellitus 2. typu $x genetika $x metabolismus $x patologie $7 D003924
650    12
$a regulace genové exprese $7 D005786
650    12
$a genetická predispozice k nemoci $7 D020022
650    _2
$a glukózový toleranční test $7 D005951
650    _2
$a lidé $7 D006801
650    _2
$a leukocyty mononukleární $x metabolismus $x patologie $7 D007963
650    _2
$a lipopolysacharidové receptory $x metabolismus $7 D018950
650    _2
$a mužské pohlaví $7 D008297
650    12
$a transkriptom $7 D059467
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Šiklová, Michaela $u Department for Pathophysiology, Centre for Research on Nutrition, Metabolism and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czechia $u Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague, and Inserm, Toulouse, France
700    1_
$a Šrámková, Veronika $u Department for Pathophysiology, Centre for Research on Nutrition, Metabolism and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czechia $u Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague, and Inserm, Toulouse, France
700    1_
$a Štěpán, Marek $u Department for Pathophysiology, Centre for Research on Nutrition, Metabolism and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czechia $u Department of Internal Medicine, Third Faculty of Medicine, Charles University, and Kralovske Vinohrady University Hospital, Prague, Czechia
700    1_
$a Krauzová, Eva $u Department for Pathophysiology, Centre for Research on Nutrition, Metabolism and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czechia $u Department of Internal Medicine, Third Faculty of Medicine, Charles University, and Kralovske Vinohrady University Hospital, Prague, Czechia
700    1_
$a Štich, Vladimír $u Department for Pathophysiology, Centre for Research on Nutrition, Metabolism and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czechia $u Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague, and Inserm, Toulouse, France $u Department of Internal Medicine, Third Faculty of Medicine, Charles University, and Kralovske Vinohrady University Hospital, Prague, Czechia
700    1_
$a Rossmeislová, Lenka $u Department for Pathophysiology, Centre for Research on Nutrition, Metabolism and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czechia $u Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague, and Inserm, Toulouse, France
773    0_
$w MED00174543 $t Frontiers in endocrinology $x 1664-2392 $g Roč. 11, č. - (2020), s. 582732
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33658980 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830100823 $b ABA008
999    __
$a ok $b bmc $g 1690135 $s 1139686
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 11 $c - $d 582732 $e 20210215 $i 1664-2392 $m Frontiers in endocrinology $n Front. endocrinol. $x MED00174543
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...